Hepatitis B: How many of the 85,000 people living with undiagnosed chronic hepatitis B are attending your practice?

Webinar summary

Date: 18 June2019

234,000 people are living with chronic hepatitis B (CHB) in Australia, but only 6 in 10 are diagnosed and 2 in 10 are engaged in regular care. The majority of people living with CHB in Australia were born overseas; Aboriginal and Torres Strait Islander people are also disproportionately affected. Treatment for CHB prevents liver damage and cancer, and can be prescribed by accredited General Practitioners. This session outlines the key populations for opportunistic hepatitis B testing, how to order diagnostic tests and interpret results, intervention points throughout the natural history, treatment options, and liver cancer surveillance.

Learning outcomes:

  • Identify priority populations for hepatitis B testing in Australia
  • Correctly order HBV diagnostic tests
  • Interpret serology to determine a patient's hepatitis B status
  • Describe the intervention points throughout the natural history of HBV using the HBV decision making tool
  • Explain the need for treatment and regular lifelong monitoring of patients with chronic hepatitis B

CPD points



Dr Nicole Allard


Dr Natalia Rode



Related documents

Webinar slides (PDF 3 MB)

Decision making tool (PDF 389 KB)